Concomitant calcium antagonist plus isosorbide dinitrate therapy for markedly active variant angina.

Winniford, M D; Gabliani, G; Johnson, S M; Mauritson, D R; Fulton, K L; Hillis, L D

Winniford, M D; Gabliani, G; Johnson, S M; Mauritson, D R; Fulton, K L; Hillis, L D.

Am Heart J ; 108(5): 1269-73, 1984 Nov.

Article in En | MEDLINE | ID: mdl-6496286

Subject(s)

Angina Pectoris, Variant/drug therapy; Calcium Channel Blockers/therapeutic use; Isosorbide Dinitrate/therapeutic use; Adult; Angina Pectoris, Variant/physiopathology; Calcium Channel Blockers/adverse effects; Drug Therapy, Combination; Electrocardiography; Female; Humans; Isosorbide Dinitrate/adverse effects; Male; Middle Aged; Nifedipine/adverse effects; Nifedipine/therapeutic use; Patient Compliance; Verapamil/adverse effects; Verapamil/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Calcium Channel Blockers / Isosorbide Dinitrate / Angina Pectoris, Variant Type of study: Clinical_trials Language: En Journal: Am Heart J Year: 1984 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links